Emma Stocker1, Sheila Johal2, Larisa Rippel3, Rebecca Darrah4,5. 1. Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA. emma.stocker@ascension.org. 2. CooperGenomics, Livingston, NJ, USA. 3. Center for Human Genetics, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. 4. Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA. 5. Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH, USA.
Abstract
PURPOSE: To identify specific likelihoods that an embryo will be classified as appropriate for transfer after preimplantation genetic testing for detection of a monogenic disorder (PGT-M), with or without preimplantation genetic testing for aneuploidy (PGT-A), separated by inheritance pattern. METHODS: Retrospective chart review of 181 selected PGT-M cycles performed at CooperGenomics in 2018 or 2019. For each cycle, the following main outcome data was collected: the number of embryos classified as affected with monogenic disease, the number detected to be chromosomally abnormal, the number that were recombinant, the number that had no result, and if applicable, the number which were aneuploid. RESULTS: There were significantly fewer embryos appropriate to consider for transfer when PGT-A was included for autosomal recessive and X-linked disorders. There were also fewer for autosomal dominant disorders, though this was not statistically significant. When PGT-A was not included, 45.8% of autosomal dominant, 69% of autosomal recessive, and 47.8% of X-linked embryos were appropriate to consider for transfer. When PGT-A analysis was included, 29% of autosomal dominant, 41% of autosomal recessive, and 22% of X-linked embryos were appropriate to consider for transfer. 96.8% of women elect to include PGT-A when pursuing PGT-M. CONCLUSION: This study resulted in specific likelihoods that an embryo would be found appropriate for clinicians and patients to consider for transfer based on the inheritance pattern of the monogenic disease being tested for and whether aneuploidy analysis was included.
PURPOSE: To identify specific likelihoods that an embryo will be classified as appropriate for transfer after preimplantation genetic testing for detection of a monogenic disorder (PGT-M), with or without preimplantation genetic testing for aneuploidy (PGT-A), separated by inheritance pattern. METHODS: Retrospective chart review of 181 selected PGT-M cycles performed at CooperGenomics in 2018 or 2019. For each cycle, the following main outcome data was collected: the number of embryos classified as affected with monogenic disease, the number detected to be chromosomally abnormal, the number that were recombinant, the number that had no result, and if applicable, the number which were aneuploid. RESULTS: There were significantly fewer embryos appropriate to consider for transfer when PGT-A was included for autosomal recessive and X-linked disorders. There were also fewer for autosomal dominant disorders, though this was not statistically significant. When PGT-A was not included, 45.8% of autosomal dominant, 69% of autosomal recessive, and 47.8% of X-linked embryos were appropriate to consider for transfer. When PGT-A analysis was included, 29% of autosomal dominant, 41% of autosomal recessive, and 22% of X-linked embryos were appropriate to consider for transfer. 96.8% of women elect to include PGT-A when pursuing PGT-M. CONCLUSION: This study resulted in specific likelihoods that an embryo would be found appropriate for clinicians and patients to consider for transfer based on the inheritance pattern of the monogenic disease being tested for and whether aneuploidy analysis was included.
Authors: Santiago Munné; Brian Kaplan; John L Frattarelli; Tim Child; Gary Nakhuda; F Nicholas Shamma; Kaylen Silverberg; Tasha Kalista; Alan H Handyside; Mandy Katz-Jaffe; Dagan Wells; Tony Gordon; Sharyn Stock-Myer; Susan Willman Journal: Fertil Steril Date: 2019-09-21 Impact factor: 7.329
Authors: Manuel Viotti; Andrea R Victor; Frank L Barnes; Christo G Zouves; Andria G Besser; James A Grifo; En-Hui Cheng; Maw-Sheng Lee; Jose A Horcajadas; Laura Corti; Francesco Fiorentino; Francesca Spinella; Maria Giulia Minasi; Ermanno Greco; Santiago Munné Journal: Fertil Steril Date: 2021-03-06 Impact factor: 7.329
Authors: Iris G Insogna; A Lanes; L Dobson; E S Ginsburg; C Racowsky; E Yanushpolsky Journal: J Assist Reprod Genet Date: 2021-03-03 Impact factor: 3.412